Nanexa signs additional collaboration agreement for evaluation of PharmaShell®
Pressrelease
Uppsala 17th December 2018
Nanexa signs additional collaboration agreements for evaluation of PharmaShell®
A Swedish biotech company has today signed an agreement with Nanexa to evaluate PharmaShell® as a drug delivery technology for a specific substance but also as a drug delivery platform for the biotech company’s development portfolio.
Nanexa signs agreement with pharmaceutical company for evaluation of PharmaShell®
Pressrelease
Uppsala 17th December 2018
Nanexa signs agreement with pharmaceutical company for evaluation of PharmaShell®
A Swedish listed pharmaceutical company begins evaluating Nanexa’s drug delivery platform PharmaShell® as a possible technology to use in a specific product development project.
